Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Devonian Health Group, Inc. (TSE:GSD)
:GSD
Holding TSE:GSD?
Track your performance easily
GSD Stock Chart & Stats
Day’s Range― - ―
52-Week RangeC$0.08 - C$0.35
Previous CloseN/A
VolumeN/A
Average Volume (3M)12.66K
Market Cap
C$23.72M
Enterprise ValueN/A
Total Cash (Recent Filing)$2.20M
Total Debt (Recent Filing)$3.10M
Price to Earnings (P/E)―
Beta1.42
Next Earnings
Mar 27, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding148,222,530
10 Day Avg. Volume2,400
30 Day Avg. Volume12,665
Standard Deviation0.29
R-Squared0.05
Alpha0.03
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)2.43
Price to Cash Flow (P/CF)23.00
P/FCF Ratio17.10
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Devonian Health Group, Inc. News
PremiumCompany Announcements
Devonian Health Sees Revenue Surge Amid Stock Option Grants
PremiumCompany Announcements
Devonian Health Reports Significant Revenue Growth
PremiumCompany Announcements
Devonian Health Group Issues New Stock Options
PremiumCompany Announcements
Devonian Health Group Revamps Shares and CFO Steps Down
PremiumCompany Announcements
Devonian Health Group to Feature in Virtual Investor Event
PremiumCompany Announcements
Devonian Health Spotlights Innovation at Virtual RoadshowPremiumCompany Announcements
Devonian Health’s Revenue Soars with Clinical Advances
PremiumCompany Announcements
Devonian Health Group Joins Renmark Virtual RoadshowGSD FAQ
What was Devonian Health Group, Inc.’s price range in the past 12 months?
Devonian Health Group, Inc. lowest stock price was C$0.07 and its highest was C$0.35 in the past 12 months.
What is Devonian Health Group, Inc.’s market cap?
Devonian Health Group, Inc.’s market cap is C$23.72M.
When is Devonian Health Group, Inc.’s upcoming earnings report date?
Devonian Health Group, Inc.’s upcoming earnings report date is Mar 27, 2025 which is in 67 days.
How were Devonian Health Group, Inc.’s earnings last quarter?
Currently, no data Available
Is Devonian Health Group, Inc. overvalued?
According to Wall Street analysts Devonian Health Group, Inc.’s price is currently Overvalued.
Does Devonian Health Group, Inc. pay dividends?
Devonian Health Group, Inc. does not currently pay dividends.
What is Devonian Health Group, Inc.’s EPS estimate?
Devonian Health Group, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Devonian Health Group, Inc. have?
Devonian Health Group, Inc. has 148,222,530 shares outstanding.
What happened to Devonian Health Group, Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Devonian Health Group, Inc.?
Currently, no hedge funds are holding shares in TSE:GSD
---
Company Description
Devonian Health Group, Inc.
Devonian Health Group Inc is operating in the pharmaceutical sector. It is engaged in the development of botanical drugs. The group is also involved in the development of value-added products for dermo-cosmetics. It is intended to develop prescription botanical drugs which could be from plant materials, algae, macroscopic fungi, and combinations thereof. The company's technology platform, The Supra Molecular Complex Extraction, and Stabilization Technology provide a process of extraction, purification, stabilization, and conditioning of molecular complexes, as active botanical ingredients, from plants and algae. The products of the group include botanical pharmaceuticals, Thykamine; and derma-cosmeceutical product, Purgenesis.
---
Technical Analysis
---